Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abbott
Abbott Completes Visiogen Acquisition
November 7th, 2009
Abbott (NYSE:ABT) announced that it has completed its acquisition of privately held eye care company Visiogen, expanding the company's vision care business with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients. Visiogen's Synchrony=AE accommodating IOL is a significant advancement in artificial lens technology. It is designed to mimic the eye's natural ability to change focus (accommodation), delivering improved vision at all distances, potentially eliminating the need for glasses or contact lenses, reducing glare and nighttime halos, and improving contrast sensitivity. Abbott's $400...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2009-11-07)
|
